ORMP
Oramed Pharmaceuticals Inc
4.70$
+1.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| – | – | 76.4% | 7.6% | 3.5% | 3.3% | 3.3% | – | – | – | – | 99.4% | |
| – | – | 23.6% | 92.4% | 96.5% | 96.7% | 100.0% | 100.0% | 100.0% | 100.0% | – | 0.7% | |
| – | – | 1,202.7% | 418.6% | 489.1% | 500.3% | 377.7% | 776.5% | 1,022.5% | 669.5% | – | 319.1% | |
| – | – | 382.5% | 112.3% | 166.7% | 137.7% | 156.2% | 219.6% | 511.0% | 628.7% | – | 436.0% | |
| – | – | 1,585.2% | 530.9% | 655.9% | 638.0% | 533.8% | 996.2% | 1,602.0% | 1,276.8% | – | 755.1% | |
| – | – | -1,561.6% | -438.6% | -552.3% | -541.3% | -433.8% | -896.2% | -1,502.0% | -1,176.8% | – | -754.4% | |
| – | – | 1.7% | 0.2% | 0.2% | 4.7% | – | 0.2% | 108.5% | 267.2% | – | 0.0% | |
| – | – | -1,502.2% | -410.4% | -519.7% | -520.0% | -424.8% | -850.5% | -1,393.4% | 379.7% | – | 3,766.2% | |
| – | – | 208.3% | 16.3% | -32.7% | 11.1% | 7.1% | -106.5% | 3.7% | – | – | 565.4% | |
| – | – | -1,710.5% | -426.7% | -519.7% | -531.1% | -424.8% | -822.7% | -1,397.1% | 412.3% | – | 3,202.5% | |
| – | – | -1,558.3% | -437.9% | -550.9% | -524.3% | -433.6% | -893.3% | -1,368.0% | 546.3% | – | 3,772.2% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.